| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/02/1997 | EP0750496A1 Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents |
| 01/02/1997 | EP0750493A1 Method for making chewable tablets based on troxerutine, calcium carbonate, calcium phosphate, arginine aspartate, arginine glutamate, amoxicillin, a combination of calcium carbonate and magnesium carbonate, and a combination of aluminium hydroxide and magnesium hydroxide |
| 01/02/1997 | EP0680328B1 Topical ketoconazole compositions |
| 01/02/1997 | EP0564461B1 The use of antibodies to tnf or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor |
| 01/02/1997 | EP0552178B1 Modified ribozymes |
| 01/02/1997 | EP0550631B1 Compounds having antihypertensive and anti-ischemic properties |
| 01/02/1997 | DE19625027A1 Medicament prepn. for prodn. of propellant gas-free aerosol |
| 01/02/1997 | DE19525017A1 Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption Pharmaceutical Kombinatonspräparat, kit and method for hormonal contraception |
| 01/02/1997 | DE19522472A1 Prepn. of natural healing prods. for treatment of prostate disorders |
| 01/01/1997 | CN1139435A New ginkgolide derivatives and process for preparing them |
| 01/01/1997 | CN1139434A Diazabicyclic neurokinin antagonists |
| 01/01/1997 | CN1139432A Prodrugs of inhibitor of HIV protease |
| 01/01/1997 | CN1139431A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders |
| 01/01/1997 | CN1139430A Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 01/01/1997 | CN1139429A Process for the preparation of leukotriene antagonists |
| 01/01/1997 | CN1139427A Malarial aspartic protease inhibitors |
| 01/01/1997 | CN1139386A Microcapsules, method of making and their use |
| 01/01/1997 | CN1139384A Use of mometasone furoate for treating airway passage and lung diseases |
| 01/01/1997 | CN1139383A Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 01/01/1997 | CN1139382A Modified-release metronidazole compositions and methods for making and using same |
| 01/01/1997 | CN1139380A Controlled release preparation |
| 01/01/1997 | CN1139111A Novel pyridine compounds, processes for their preparation and pharmaceutical compositions which contain them |
| 01/01/1997 | CN1139110A Inhibitng photodecomposition of 3-substituted-2-oxindoles |
| 01/01/1997 | CN1139108A Substituted benzothienylpiperazines their use as medicaments, and processes for their preparation |
| 01/01/1997 | CN1139105A Stable microemulsions of certain 3-isothiazolone compounds |
| 01/01/1997 | CN1138998A Herba Pteridis semipinnatae extract and its medicinal composite |
| 01/01/1997 | CN1138985A Application of cereb in medicine for optic atrophy and its compound prepn |
| 01/01/1997 | CN1138984A Anti-thrombosis glucoside medicine |
| 01/01/1997 | CN1138983A Preparation of drug composition |
| 01/01/1997 | CN1033701C Preparation of 9-(2-hydroxy-ethoxy-methyl) guanine derivative |
| 12/31/1996 | US5589594 Process for the preparation of cephem prodrug esters |
| 12/31/1996 | US5589593 Crystalline form of a cephalosporin antibiotic |
| 12/31/1996 | US5589515 Cosmetic composition and an emulsion composition |
| 12/31/1996 | US5589514 Arylcycloalkyl derivatives, their production and their use |
| 12/31/1996 | US5589513 Pharmaceutical composition and process for the preparation thereof |
| 12/31/1996 | US5589512 Diagnosis of psychological disorders |
| 12/31/1996 | US5589511 Method for treating migraine headaches using optically pure S(+) fluoxetine |
| 12/31/1996 | US5589510 Method for inhibiting retroviral infection by administering a naphthalenesulfonic acid compound |
| 12/31/1996 | US5589509 Enhancing effect of administered tumor cell-locating porphyrins in light irradiation to destroy tumor cells |
| 12/31/1996 | US5589508 Use of an emulsion to prepare an intravensously administered medicament for treating skin diseases |
| 12/31/1996 | US5589505 Method of treating wrinkles using quinic acid or quinolactone |
| 12/31/1996 | US5589504 Treatment of newborn jaundice |
| 12/31/1996 | US5589503 Endoparasiticidal compositions |
| 12/31/1996 | US5589501 Pharmaceutical compounds |
| 12/31/1996 | US5589500 Substituted 1,1,2-triphenylbutenes and their use in the treatment of cancer |
| 12/31/1996 | US5589499 Dopaminergic agents for the treatment of cerebral and peripheral blood flow disorders |
| 12/31/1996 | US5589498 Plasticizing and solvent type enhancers, porous membranes, hydrogels, foams |
| 12/31/1996 | US5589497 Antiandrogens |
| 12/31/1996 | US5589496 Fused benzeneoxyacetic acid derivatives which have PGI2 receptor agonist activity |
| 12/31/1996 | US5589495 2-[(3-heteroaryl-1-pyrrolidinyl)alkyl]-1,3- indandiones and related compounds and their therapeutic utility |
| 12/31/1996 | US5589494 2-[(3-heteroaryl-1-pyrrolidinyl)alkyl]-1,3-dioxanes and related compounds and their therapeutic utility |
| 12/31/1996 | US5589491 Injection and injection kit containing omeprazole and its analogs |
| 12/31/1996 | US5589490 Benzoic acid substituted derivatives having cardiovascular activity |
| 12/31/1996 | US5589489 Cyclic amide derivatives for treating asthma |
| 12/31/1996 | US5589488 Antipsychotic agents, analgesics |
| 12/31/1996 | US5589487 Piperidine derivatives and process for their production |
| 12/31/1996 | US5589486 N-hydroxyalkyl-substituted 1,2,3,6-tetrahydro-pyridine and piperidine derivatives |
| 12/31/1996 | US5589484 Treatment of helicobacter infections, antiulcer |
| 12/31/1996 | US5589483 Isoquinoline poly (ADP-ribose) polymerase inhibitors to treat skin diseases associated with cellular senescence |
| 12/31/1996 | US5589482 Benzo-thiophene estrogen agonists to treat prostatic hyperplasia |
| 12/31/1996 | US5589481 Nerve growth factor production accelerators and compositions for preventing or treating neuronal degeneration |
| 12/31/1996 | US5589480 Topical application of opioid analgesic drugs such as morphine |
| 12/31/1996 | US5589476 Imidazol-4-ylpiperidine derivatives, their preparation and their application in therapeutics |
| 12/31/1996 | US5589475 Benzodiazepine treatment |
| 12/31/1996 | US5589474 Dibenzothiazepinthione as antiviral agents |
| 12/31/1996 | US5589473 Mono- and bicyclic DNA gyrase inhibitors |
| 12/31/1996 | US5589471 Vitamin D analogues containing a hydroxy or alkylated hydroxy group in the 20-position |
| 12/31/1996 | US5589470 Reducing tetracycline resistance in living cells |
| 12/31/1996 | US5589468 Method for providing nutrition to elderly patients |
| 12/31/1996 | US5589467 2,5',N6-trisubstituted adenosine derivatives |
| 12/31/1996 | US5589465 Glycolipid derivatives acting as ligands for selectins |
| 12/31/1996 | US5589464 Use of 2-substituted-thiazolidine-4-carboxylic acids for treatment of cataract |
| 12/31/1996 | US5589463 Oral delivery of biologically active substances bound to vitamin B12 |
| 12/31/1996 | US5589374 Diabetogene rad: a type II diabetes specific gene |
| 12/31/1996 | US5589366 Process for producing antiparasitic macrolide antibiotics |
| 12/31/1996 | US5589192 Gel pharmaceutical formulation for local anesthesia |
| 12/31/1996 | US5589191 Slow-release sodium valproate tablets |
| 12/31/1996 | US5589190 Sustained-release compositions of alfuzosin hydrochloride |
| 12/31/1996 | US5589185 Nonsteroidal antiinflammatory agents |
| 12/31/1996 | US5589184 Pharmaceutical compositions and methods of treatment of the cornea following laser treatment |
| 12/31/1996 | US5589180 Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine |
| 12/31/1996 | US5589179 Composition containing a non-photocatalytic metal oxide and tocopherol, its use in the cosmetics and/or dermatological field and processes employing it |
| 12/31/1996 | US5589178 Cosmetic and/or dermatological composition for the treatment of aging, containing ceramides, and the use thereof |
| 12/31/1996 | US5589161 Pigmentation enhancer and method |
| 12/31/1996 | US5589156 Prilocaine and hydrofluourocarbon aerosol preparations |
| 12/31/1996 | US5589047 Using dielectrophoresis for genetic engineering |
| 12/31/1996 | US5588422 Methods and pharmaceutical compositions for enhanced cardiopulmonary resuscitation |
| 12/31/1996 | CA2180280A1 Adenyl-cyclase-hemolysin (ac-hly)-protecting epitopes; use thereof for the treatment or the prevention of infections by bordetella |
| 12/31/1996 | CA2180206A1 Freeze-dried preparation for pharmaceutical use |
| 12/31/1996 | CA2092983C Hydroxylated metabolites and derivatives of doxazosin as anti-atherosclerosis agents |
| 12/31/1996 | CA2054752C Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine |
| 12/31/1996 | CA1338823C Platinum-polymer complexes and their use as antitumor agents |
| 12/31/1996 | CA1338819C Transdermal estradiol delivery system |
| 12/30/1996 | CA2177558A1 Cellulose ester wound dressing |
| 12/29/1996 | CA2180193A1 Enhancing host immunity against viral infections |
| 12/29/1996 | CA2178680A1 In vivo treatment of mammalian tissue with a metabotropic glutamate receptor agonist |
| 12/28/1996 | CA2180029A1 Oxaindene derivatives and process for the preparation thereof |
| 12/28/1996 | CA2179939A1 Pyridazinone derivatives and processes for preparing the same |
| 12/28/1996 | CA2178684A1 Anthracycline prodrugs, method for preparation as well as their use in selective chemotherapy |
| 12/27/1996 | WO1996041873A1 Dry powder formulations of polynucleotide complexes |